Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • Signal News Directory
  • News
  • Page 3

News

  • News

BridgeBio Touts Kidney-Protective Benefit for Attruby in ATTR-CM

pharminent July 6, 2026
  • News

Novartis Acquires UK ADC Specialist Myricx Bio for Up to $1.5 Billion

pharminent July 6, 2026
  • News

BioNTech Held Buyer Talks Over Four German Sites Set to Close, Handelsblatt Reports

pharminent July 3, 2026
  • News

Roche’s Divarasib Beats Amgen and BMS Head-to-Head in Phase 3 KRAS Lung Cancer Trial

pharminent July 2, 2026
  • News

Biogen Bets on Tau at AAIC: Diranersen Phase 2 CELIA Data

pharminent July 2, 2026
  • News

Ipsen Acquires Memo Therapeutics for Up to €700M in Second Deal in Three Days

pharminent July 1, 2026
  • News

Lilly’s Jaypirca Wins CHMP Opinion for CLL Across All Lines

pharminent June 30, 2026
  • News

NEJM Retracts Pivotal Tavneos Paper as Amgen’s FDA Data-Integrity Fight Deepens

pharminent June 30, 2026
  • News

BridgeBio’s Oral Achondroplasia Pill Shows Growth, Proportionality Win

pharminent June 29, 2026
  • News

Viridian’s Lumvoa Wins FDA Approval, Taking Direct Aim at Amgen’s Tepezza in Thyroid Eye Disease

pharminent June 29, 2026
  • News

Lilly Medicare GLP-1 Bridge Launches July 1 With Foundayo and Zepbound

pharminent June 26, 2026
  • News

Moderna Maps R&D ‘Horizons’ as 2028 Break-Even Goal Looms

pharminent June 26, 2026

Posts pagination

Previous 1 2 3
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.